Papers
2
Total Citations
325
H-Index
2
About
Anna M. Marcinow is a leading surgical oncologist whose research has fundamentally reshaped the treatment of oropharyngeal cancer, particularly through the advancement of transoral robotic surgery (TORS). Her work centers on improving patient quality of life (QOL) without compromising oncologic outcomes. In her landmark 2013 study (225 citations), she demonstrated that TORS offers a less QOL-impairing alternative to traditional open surgery for oropharyngeal squamous cell carcinoma (OPSCC), a critical finding for older patients who face heightened risks of functional decline. Her earlier 2011 prospective study (100 citations) provided the first long-term, health-related quality-of-life (HRQOL) data for TORS patients, establishing a new benchmark for functional recovery after head and neck cancer treatment. By systematically documenting swallowing, speech, and overall well-being outcomes, Marcinow has given clinicians evidence to prioritize less invasive approaches. Her work has been instrumental in shifting the standard of care toward robotic surgery, reducing hospital stays and preserving patients’ ability to eat and speak normally. For students and researchers, Marcinow’s research exemplifies how surgical innovation can be rigorously tested against patient-centered endpoints, making her a pivotal figure in modern head and neck oncology.
Research Focus
Key Achievements
Top Papers
- 1Transoral Robotic Surgery for Oropharyngeal Cancer225 citations · 2013
- 2Quality‐of‐Life Outcomes in Transoral Robotic Surgery100 citations · 2011